Anjali Sadhwani1, Lisa A Asaro2, Caren Goldberg3, Janice Ware4, Jennifer Butcher5, Michael Gaies3, Cynthia Smith3, Jamin L Alexander6, David Wypij7, Michael S D Agus6. 1. Cardiac Neurodevelopmental Program, Boston Children's Hospital and Harvard Medical School, Boston, MA; Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston, MA. Electronic address: anjali.sadhwani@childrens.harvard.edu. 2. Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, MA. 3. Division of Cardiology, C.S. Mott Children's Hospital and University of Michigan Medical School, Ann Arbor, MI; Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital and University of Michigan Medical School, Ann Arbor, MI. 4. Cardiac Neurodevelopmental Program, Boston Children's Hospital and Harvard Medical School, Boston, MA; Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston, MA. 5. Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital and University of Michigan Medical School, Ann Arbor, MI; Division of Pediatric Psychology, C.S. Mott Children's Hospital and University of Michigan Medical School, Ann Arbor, MI. 6. Division of Medicine Critical Care, Boston Children's Hospital and Harvard Medical School, Boston, MA. 7. Department of Cardiology, Boston Children's Hospital and Harvard Medical School, Boston, MA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.
Abstract
OBJECTIVE: To assess the association of postoperative tight glycemic control and hypoglycemia in children undergoing cardiac surgery with neurodevelopmental outcomes at 1 year of age. STUDY DESIGN: A 2-center, prospective, randomized trial of postoperative tight glycemic control vs standard care was conducted in 980 children undergoing cardiac surgery. Neurodevelopmental outcomes were assessed at nine to 18 months using the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), the Adaptive Behavior Assessment System, Second Edition, the Ages and Stages Questionnaire, Third Edition, and the Brief Infant Toddler Social-Emotional Assessment. RESULTS: Neurodevelopmental follow-up was performed on 237 patients with a mean age of 13 months. No significant treatment group differences were found in the Bayley-III and Adaptive Behavior Assessment System, Second Edition composite scores or percentage at risk based on the Ages and Stages Questionnaire, Third Edition and the Brief Infant Toddler Social-Emotional Assessment. Patients who experienced moderate to severe hypoglycemia (n = 8) had lower Bayley-III composite scores compared with patients with no to mild hypoglycemia, even after controlling for factors known to be associated with poorer neurodevelopmental outcomes. CONCLUSION: For infants undergoing cardiac surgery, tight glycemic control did not impact neurodevelopmental outcomes compared with standard care. These data suggest a possible association between moderate to severe hypoglycemia and poorer neurodevelopmental outcomes at 1 year of age. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00443599.
RCT Entities:
OBJECTIVE: To assess the association of postoperative tight glycemic control and hypoglycemia in children undergoing cardiac surgery with neurodevelopmental outcomes at 1 year of age. STUDY DESIGN: A 2-center, prospective, randomized trial of postoperative tight glycemic control vs standard care was conducted in 980 children undergoing cardiac surgery. Neurodevelopmental outcomes were assessed at nine to 18 months using the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), the Adaptive Behavior Assessment System, Second Edition, the Ages and Stages Questionnaire, Third Edition, and the Brief Infant Toddler Social-Emotional Assessment. RESULTS: Neurodevelopmental follow-up was performed on 237 patients with a mean age of 13 months. No significant treatment group differences were found in the Bayley-III and Adaptive Behavior Assessment System, Second Edition composite scores or percentage at risk based on the Ages and Stages Questionnaire, Third Edition and the Brief Infant Toddler Social-Emotional Assessment. Patients who experienced moderate to severe hypoglycemia (n = 8) had lower Bayley-III composite scores compared with patients with no to mild hypoglycemia, even after controlling for factors known to be associated with poorer neurodevelopmental outcomes. CONCLUSION: For infants undergoing cardiac surgery, tight glycemic control did not impact neurodevelopmental outcomes compared with standard care. These data suggest a possible association between moderate to severe hypoglycemia and poorer neurodevelopmental outcomes at 1 year of age. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00443599.
Authors: Kupper A Wintergerst; Bruce Buckingham; Laura Gandrud; Becky J Wong; Saraswati Kache; Darrell M Wilson Journal: Pediatrics Date: 2006-07 Impact factor: 7.124
Authors: Michael S D Agus; Lisa A Asaro; Garry M Steil; Jamin L Alexander; Melanie Silverman; David Wypij; Michael G Gaies Journal: Circulation Date: 2014-03-26 Impact factor: 29.690
Authors: Dirk Vlasselaers; Ilse Milants; Lars Desmet; Pieter J Wouters; Ilse Vanhorebeek; Ingeborg van den Heuvel; Dieter Mesotten; Michael P Casaer; Geert Meyfroidt; Catherine Ingels; Jan Muller; Sophie Van Cromphaut; Miet Schetz; Greet Van den Berghe Journal: Lancet Date: 2009-01-26 Impact factor: 79.321
Authors: Ilana Zeltser; Gail P Jarvik; Judy Bernbaum; Gil Wernovsky; Alex S Nord; Marsha Gerdes; Elaine Zackai; Robert Clancy; Susan C Nicolson; Thomas L Spray; J William Gaynor Journal: J Thorac Cardiovasc Surg Date: 2008-01 Impact factor: 5.209
Authors: Duncan Macrae; Richard Grieve; Elizabeth Allen; Zia Sadique; Kevin Morris; John Pappachan; Roger Parslow; Robert C Tasker; Diana Elbourne Journal: N Engl J Med Date: 2014-01-09 Impact factor: 91.245
Authors: Mark J Peters; Andrew Argent; Marino Festa; Stéphane Leteurtre; Jefferson Piva; Ann Thompson; Douglas Willson; Pierre Tissières; Marisa Tucci; Jacques Lacroix Journal: Intensive Care Med Date: 2017-03-17 Impact factor: 17.440
Authors: Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres Journal: Intensive Care Med Date: 2020-02 Impact factor: 17.440
Authors: Katherine V Biagas; Veronica J Hinton; Natalie R Hasbani; Peter M Luckett; David Wypij; Vinay M Nadkarni; Michael S D Agus Journal: J Pediatr Date: 2020-01-03 Impact factor: 4.406
Authors: Michael Sd Agus; Ellie Hirshberg; Vijay Srinivasan; Edward Vincent Faustino; Peter M Luckett; Martha Aq Curley; Jamin Alexander; Lisa A Asaro; Kerry Coughlin-Wells; Donna Duva; Jaclyn French; Natalie Hasbani; Martha T Sisko; Carmen L Soto-Rivera; Garry Steil; David Wypij; Vinay M Nadkarni Journal: Contemp Clin Trials Date: 2016-12-30 Impact factor: 2.226